Transduction of MHC-class I negative allogeneic cell line to improve the efficacy of anti-tumor vaccination.
Curti
A
A
Institute of Hematology and Clinical Oncology "Seràgnoli", University of Bologna, Bologna, Italy. acurti@alnia.unibo.it
Colombo
M P
MP
Baccarani
M
M
Lemoli
R M
RM
D000818:Animals; D019496:Cancer Vaccines; D002460:Cell Line; D016207:Cytokines / Q000378:metabolism; D005805:Genes, MHC Class I; D006801:Humans; D020014:K562 Cells; D051379:Mice; D008810:Mice, Inbred C57BL; D009369:Neoplasms / Q000517:prevention & control / Q000628:therapy*; D014161:Transduction, Genetic; D014162:Transfection; D014184:Transplantation, Homologous; D014407:Tumor Cells, Cultured
D019496:Cancer Vaccines; D016207:Cytokines